Abstract
Objective
A compelling strategy for treatment of spinal cord injury is the blockade of integrin-mediated leukocyte extravasation using a monoclonal antibody (mAb) against the α4 subunit of the α4β1-integrin. However, little is known with respect to neutrophil function following anti-α4 mAb treatment. This study assessed the effects of anti-α4 mAb binding on neutrophil activation [reactive oxygen species (ROS) production], function (phagocytic activity) and anti-α4-mAb/α4β1-integrin-complex internalization.
Methods
Resting, primed or stimulated rat neutrophils were incubated ex vivo with anti-α4 mAb or isotype-control antibody. ROS production, phagocytic activity, and anti-α4-mAb/α4β1-integrin-complex internalization were determined by flow cytometry using dihydrorhodamine (DHR1,2,3), fluorescent microspheres, and indirect immunolabeling, respectively.
Results
Brief (0.5 h) incubation of resting, primed or activated neutrophils with anti-α4 mAb had no effect on ROS production and did not change neutrophil phagocytic activity. However, prolonged incubation (2 h), assessed only in resting neutrophils, increased ROS production. The anti-α4-mAb/α4β1-integrin-complex was internalized after 1 h of anti-α4 mAb treatment and remained internalized up to 6 h.
Conclusion
Neutrophil ROS production and phagocytic function remain unaltered after brief anti-α4 mAb exposure, demonstrating that use of this mAb as a treatment should not adversely affect important beneficial roles of these cells.
Similar content being viewed by others
References
Yednock TA, Cannon C, Vandevert C, Goldbach EG, Shaw G, Ellis DK, et al. Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem. 1995;270:28740–50.
Davenpeck KL, Sterbinsky SA, Bochner BS. Rat neutrophils express alpha4 and beta1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Blood. 1998;91:2341–6.
Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity. 2004;20:455–65.
Engelhardt B, Briskin MJ. Therapeutic targeting of alpha4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit? Eur J Immunol. 2005;35:2268–73.
Engelhardt B, Kappos L. Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis. 2008;5:16–22.
Fabene PF, Mora GN, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14:1377–83.
Fleming JC, Bao F, Chen Y, Hamilton EF, Relton JK, Weaver LC. α4β1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol. 2008;214:147–59.
Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond). 1998;94:461–71.
Jakus Z, Berton G, Ligeti E, Lowell CA, Mocsai A. Responses of neutrophils to anti-integrin antibodies depends on costimulation through low affinity Fc gamma Rs: full activation requires both integrin and nonintegrin signals. J Immunol. 2004;173:2068–77.
Williams MA, Solomkin JS. Integrin-mediated signaling in human neutrophil functioning. J Leukoc Biol. 1999;65:725–36.
Pereira S, Zhou M, Mocsai A, Lowell C. Resting murine neutrophils express functional alpha 4 integrins that signal through Src family kinases. J Immunol. 2001;166:4115–23.
Chan JR, Hyduk SJ, Cybulsky MI. Alpha 4 beta 1 integrin/VCAM-1 interaction activates alpha L beta 2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol. 2000;164:746–53.
Van den Berg JM, Mul FP, Schippers E, Weening JJ, Roos D, Kuijpers TW. Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin. Eur J Immunol. 2001;31:276–84.
Yurochko AD, Liu DY, Eierman D, Haskill S. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA. 1992;89:9034–8.
Leussink VI, Zettl UK, Jander S, Pepinsky RB, Lobb RR, Stoll G, et al. Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis. Acta Neuropathol (Berl). 2002;103:131–6.
Wileman T, Harding C, Stahl P. Receptor-mediated endocytosis. Biochem J. 1985;232:1–14.
Leone DR, Giza K, Gill A, Dolinski BM, Yang W, Perper S, et al. An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther. 2003;305:1150–62.
Li W, Chung SC. Flow cytometric evaluation of leukocyte function in rat whole blood. In Vitro Cell Dev Biol AnimTW. 2003;39:413–9.
Cepinskas G, Lush CW, Kivetys PR. Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells: a nuclear factor-kB-mediated phenomenon. Circ Res. 1999;84:103–12.
Snedecor G, Cochran W. Statistical methods. Iowa: Iowa State University Press; 1989.
Bao F, Bailey CS, Gurr KR, Bailey SI, Rosas-Arellano MP, Dekaban GA, et al. Increased oxidative activity in human circulating leukocytes in response to spinal cord injury. Exp Neurol. 2009;215:308–16.
Ibbotson GC, Doig C, Kaur J, Gill V, Ostrovsky L, Fairhead T, et al. Functional alpha4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat Med. 2001;7:465–70.
Wang CX, Nuttin B, Heremans H, Dom R, Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol. 1996;69:151–6.
Fuortes M, Jin WW, Nathan C. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor. J Cell Biol. 1993;120:777–84.
Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res. 2005;65:16–27.
Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci. 2007;25:1743–7.
Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol. 2007;207:75–84.
Cruse JM, Lewis RE, Bishop GR, Kliesch WF, Gaitan E. Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients. Immunol Res. 1992;11:104–16.
Cruse JM, Lewis RE, Dilioglou S, Roe DL, Wallace WF, Chen RS. Review of immune function, healing of pressure ulcers, and nutritional status in patients with spinal cord injury. J Spinal Cord Med. 2000;23:129–35.
Furlan JC, Krassioukov AV, Fehlings MG. Hematologic abnormalities within the first week after acute isolated traumatic cervical spinal cord injury: a case-control cohort study. Spine. 2006;31:2674–83.
DeVivo MJ, Krause JS, Lammertse D. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411–9.
Ackery A, Tator C, Krassioukov A. A global perspective on spinal cord injury epidemiology. J Neurotrauma. 2004;21:1355–70.
Stirling DP, Liu S, Kubes P, Yong VW. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci. 2009;29:753–64.
Santos JL, Montes MJ, Gutierrez F, Ruiz C. Evaluation of phagocytic capacity with a modified flow cytometry technique. Immunol Lett. 1995;45:1–4.
Busetto S, Trevisan E, Patriarca P, Menegazzi R. A single-step, sensitive flow cytofluorometric assay for the simultaneous assessment of membrane-bound and ingested candida albicans in phagocytosing neutrophils. Cytometry Part A. 2004;58A:201–6.
Rubin BB, Rotstein OD, Lukacs G, Bailey D, Romaschin A, Walker PM. Decreased leukocyte adhesion with anti-CD18 monoclonal antibodies is mediated by receptor internalization. Surgery. 1992;112:263–8.
Bao F, Chen Y, Schneider KA, Weaver LC. An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol. 2008;214:160–7.
Acknowledgments
This research was supported by grants from the Canadian Institutes of Health Research, the Ontario Neurotrauma Foundation and the Lawson Health Research Institute. JC Fleming was supported by studentships from the Ontario Neurotrauma Foundation and the Canadian Institutes of Health Research. The authors are indebted to Drs. Greg Dekaban and Kristin Chadwick for their superb advice about flow cytometry. The authors also thank Drs. Arthur Brown, Feng Bao, and Canio Polosa for their constructive suggestions regarding this research.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: L. Li.
Rights and permissions
About this article
Cite this article
Fleming, J.C., Bao, F., Cepinskas, G. et al. Anti-α4β1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes. Inflamm. Res. 59, 647–657 (2010). https://doi.org/10.1007/s00011-010-0177-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-010-0177-5